stress-granule-disease-comparison

Migration, Crosslink

📖

stress-granule-disease-comparison

active

wiki page Created: 2026-04-02T07:20:02 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-stress-granule-disease-c

📖 Wiki Page

mechanism1833 wordssynced 2026-04-02

Stress Granule Dysfunction: Cross-Disease Comparison

Overview

Stress granules (SGs) are cytoplasmic RNA-protein condensates formed via liquid-liquid phase separation (LLPS) in response to cellular stress. They function as temporary storage for translationally arrested mRNAs and associated proteins, protecting cells during stress exposure. Growing evidence demonstrates that dysregulated stress granule dynamics contribute to multiple neurodegenerative diseases through distinct molecular mechanisms. This comparison examines how stress granule dysfunction manifests across Alzheimer's disease, Parkinson's disease, ALS, frontotemporal dementia, and Huntington's disease. PMID: 40868276

Cross-Disease Comparison Matrix

...

Stress Granule Dysfunction: Cross-Disease Comparison

Overview

Stress granules (SGs) are cytoplasmic RNA-protein condensates formed via liquid-liquid phase separation (LLPS) in response to cellular stress. They function as temporary storage for translationally arrested mRNAs and associated proteins, protecting cells during stress exposure. Growing evidence demonstrates that dysregulated stress granule dynamics contribute to multiple neurodegenerative diseases through distinct molecular mechanisms. This comparison examines how stress granule dysfunction manifests across Alzheimer's disease, Parkinson's disease, ALS, frontotemporal dementia, and Huntington's disease. PMID: 40868276

Cross-Disease Comparison Matrix

| Mechanism | Alzheimer's Disease | Parkinson's Disease | ALS | Frontotemporal Dementia | Huntington's Disease |
|-----------|------------------|-------------------|-----|----------------------|-------------------|
| SG Formation | Moderate ↑ | Variable | Severe ↑ | Severe ↑ | Moderate |
| LLPS Dysregulation | Aβ-mediated | LRRK2-mediated | TDP-43/FUS-mediated | TDP-43/FUS-mediated | mHTT-mediated |
| G3BP1 Alteration | G3BP1↓ in aging | Not prominent | G3BP1 sequestration | G3BP1 sequestration | Variable |
| TIA-1 Alteration | Mild | Moderate | Severe | Severe | Not prominent |
| Persistent SGs | Rare | Rare | Common | Common | Variable |
| Aggregation Seeding | Tau nucleation | α-syn nucleation | TDP-43 nucleation | TDP-43 nucleation | Mutant HTT |
| Autophagy Block | mTOR↑ blocks clearance | LRRK2 blocks clearance | Poor clearance | Poor clearance | mHTT blocks clearance |
| Translation Arrest | Prolonged | Transient | Chronic | Chronic | Variable |
| Trafficking Defect | Tau-mediated | LRRK2/DCTN1 | TDP-43/FUS | TDP-43/FUS | mHTT |

Disease-Specific Mechanisms

Alzheimer's Disease

Stress granule alterations in AD are less characterized than in ALS/FTD but contribute to translational dysfunction. PMID: 37720552

Key Alterations:

G3BP1 expression decreases with aging in AD brain
Impaired stress granule clearance via mTOR hyperactivation
Prolonged stress granule persistence affecting local translation
Potential interplay between stress granules and tau pathology
eIF2α phosphorylation alterations affecting SG dynamics

Critical Proteins:

[G3BP1](/proteins/g3bp1-protein) - Ras-GAP SH3-domain-binding protein 1
[TIA1](/proteins/tia1l-protein) - TIA-1 cytotoxic granule-associated protein
[TIA1L](/proteins/tia1l-protein) - TIA-1-like protein

Pathogenic Cascade:

Mermaid diagram (expand to render)

Parkinson's Disease

PD shows LRRK2-mediated stress granule alterations linked to genetic risk factors. PMID: 34927200

Key Alterations:

LRRK2 hyperphosphorylation of Rab proteins affects SG trafficking
GBA mutations causing glucocerebrosidase deficiency affects SG clearance
Alpha-synuclein co-localization with stress granules
Impaired autophagy-lysosomal pathway affecting SG clearance
Variable TIA-1 alterations

Critical Genes:

[LRRK2](/genes/lrrk2) - Leucine-rich repeat kinase 2
[GBA](/genes/gba) - Glucocerebrosidase
[SNCA](/genes/snca) - Alpha-synuclein
[GCH1](/genes/gch1) - GTP cyclohydrolase 1

Pathogenic Cascade:

Mermaid diagram (expand to render)

Amyotrophic Lateral Sclerosis

ALS shows the most pronounced stress granule pathology, with TDP-43 and FUS directly altering SG dynamics.

Key Alterations:

TDP-43 sequestration in stress granules (pathogenic)
FUS mutations causing SG mislocalization
C9orf72 repeat expansion affecting SG composition
G3BP1 sequestration by pathogenic proteins
Chronic persistent stress granules
Failed SG clearance leading to aggregation

Critical Genes:

[TARDBP](/genes/tardbp) - TDP-43
[FUS](/genes/fus) - Fused in sarcoma
[C9orf72](/genes/c9orf72) - Chromosome 9 open reading frame 72
[G3BP1](/genes/g3bp1) - G3BP1

Pathogenic Cascade:

Mermaid diagram (expand to render)

Frontotemporal Dementia

FTD shares significant overlap with ALS, particularly in TDP-43 pathology.

Key Alterations:

TDP-43 pathology similar to ALS
FUS mutations in some FTD cases
Progranulin deficiency affecting lysosomal function
CHMP2B mutations affecting SG clearance
TMEM106B risk variants affecting SG dynamics

Critical Genes:

[GRN](/genes/grn) - Progranulin
[MAPT](/genes/mapt) - Microtubule-associated protein tau
[TARDBP](/genes/tardbp) - TDP-43
[FUS](/genes/fus) - FUS
[TMEM106B](/genes/tmem106b) - TMEM106B

Huntington's Disease

Mutant huntingtin interferes with stress granule dynamics and SG clearance.

Key Alterations:

Mutant HTT (mHTT) recruits SG proteins
Impaired SG clearance via autophagy
Altered G3BP1 interactions
Variable SG persistence
Translation dysregulation

Critical Genes:

[HTT](/genes/htt) - Huntingtin
[HAP40](/genes/hap40) - Huntingtin-associated protein 40

Liquid-Liquid Phase Separation in Neurodegeneration

LLPS Fundamentals

Liquid-liquid phase separation underlies stress granule formation. Key regulators include:

RNA-binding proteins with low-complexity domains
Multi-valent interactions driving condensation
RNA concentration as a scaffold
Post-translational modifications modulating interactions

Cross-Disease LLPS Mechanisms

| Factor | AD | PD | ALS | FTD | HD |
|--------|----|----|-----|-----|-----|
| LCD (low-complexity domain) proteins | Variable | TIA-1 | TDP-43, FUS | TDP-43, FUS | mHTT |
| RNA scaffold | Normal | Normal | ↑ (repeat RNA) | Normal | Normal |
| PTM alterations | Phosphorylation | Phosphorylation | Phosphorylation, acetylation | Phosphorylation | Phosphorylation |
| Clearance pathways | Autophagy | Autophagy | Autophagy, UBQLN2 | Autophagy | Autophagy |

Shared Molecular Mechanisms

Stress Granule Lifecycle Dysfunction

Formation: Stress-induced RNA-protein condensate formation via LLPS

Maturation: Transition from liquid-like to more solid states

Persistence: Failure to resolve, leading to chronic SGs

Clearance: Autophagy-mediated dissolution (impaired in disease)

Therapeutic Targets

| Target | Disease | Approach | Status |
|--------|---------|----------|---------|--------|
| TDP-43 aggregation | ALS/FTD | Small molecule disaggregases | Preclinical |
| LRRK2 | PD | Kinase inhibitors | Clinical |
| Autophagy enhancement | All | mTOR inhibitors, autophagy inducers | Various |
| G3BP1 modulators | ALS/FTD | RNA-based therapeutics | Preclinical |
| Phase separation modulators | All | Small molecule modulators | Early research |

RNA Granule Trafficking

Stress granules (SGs) and other RNA granules are actively transported along microtubules in neurons, enabling spatial regulation of mRNA translation at distant synaptic sites. This trafficking is essential for neuronal function and is disrupted in multiple neurodegenerative diseases.

Motor Proteins and Transport Machinery

RNA granule transport is mediated by a coordinated system of microtubule motors:

| Motor Protein | Direction | Cargo | Disease Relevance |
|--------------|-----------|------|-------------------|
| Kinesin-1 | Anterograde (+ end) | SGs, neuronal RNA granules | Tau-mediated inhibition in AD |
| Kinesin-3 | Anterograde (+ end) | Synaptic RNA granules | Reduced in PD |
| Dynein-dynactin | Retrograde (- end) | SGs, autophagosomes | DCTN1 mutations in PD/ALS |
| BICD2 | Adapter | Dynein-dynactin | Linker protein |

Transport Mechanisms

Bidirectional Transport: SGs exhibit bidirectional movement, with net anterograde transport to distal neurites

Run-and-Tumble Dynamics: Motor binding/unbinding creates characteristic movement patterns

Motor Switching: Kinesins and dynein compete for binding sites on RNA granules

Dynactin Enhancement: Dynactin increases dynein processivity by 5-10x

Disease-Specific Transport Dysfunction

Alzheimer's Disease

Tau pathology directly inhibits kinesin-dependent transport
Hyperphosphorylated tau sequesters kinesin motors
Reduced SG delivery to distal synapses
Impaired local protein synthesis at synapses

Molecular Cascade:

Mermaid diagram (expand to render)

Parkinson's Disease

LRRK2 mutations hyperphosphorylate Rab proteins
Rab mislocalization affects SG transport machinery
DCTN1 (p150Glued) mutations cause Perry syndrome
Reduced dynein-dynactin function impairs retrograde transport
Autophagosome delivery to cell body is blocked

Molecular Cascade:

Mermaid diagram (expand to render)

ALS/FTD

TDP-43 pathology sequesters transport proteins
FUS mutations alter SG transport to synapses
C9orf72 dipeptide repeats disrupt transport machinery
DCTN1 mutations cause motor neuron degeneration
Impaired delivery of SGs to neuromuscular junctions

Molecular Cascade:

Mermaid diagram (expand to render)

Huntington's Disease

Mutant huntingtin directly impairs transport
Huntingtin-associated protein 40 (HAP40) affects motor coupling
Reduced SG trafficking to dendrites
Impaired synaptic plasticity

Therapeutic Targets for Transport

| Target | Approach | Disease | Status |
|--------|----------|---------|--------|
| Tau-microtubule binding | Tau aggregation inhibitors | AD | Clinical |
| Kinesin modulators | Small molecules | AD | Preclinical |
| Dynein-dynactin enhancement | Gene therapy | ALS | Preclinical |
| Dynactin stabilizers | Biologics | PD | Discovery |
| Transport enhancers | Microtubule stabilizers | Multiple | Phase 1 |

Transport Assays

| Method | Readout | Application |
|--------|---------|-------------|
| Live-cell imaging | SG velocity, run length | Drug screening |
| FRAP | Recovery kinetics | Mechanism study |
| Neuronal tracing | Cargo delivery | In vivo models |
| Calibrated systems | Motor activity | Target validation |

Clinical Trials

| Trial ID | Intervention | Target Disease | Phase |
|----------|--------------|---------------|-------|
| NCT05676532 | Rapamycin | ALS | Phase 2 |
| NCT05462106 | Trehalose | ALS/FTD | Phase 2 |
| NCT05231265 | Arimoclomol | ALS | Phase 3 |
| NCT03816960 | Lithium | ALS | Phase 2 |

Biomarkers

Fluid Biomarkers

TDP-43 fragments in CSF (ALS/FTD)
Neurofilament light chain (NfL) - general neurodegeneration marker
G3BP1 - emerging SG marker

Imaging Biomarkers

PET ligands for protein aggregates under development
Diffusion MRI for white matter integrity

References

[Systemic Neurodegeneration and Brain Aging: Multi-Omics Disintegration, Proteostatic Collapse, and Network Failure Across the CNS.](https://pubmed.ncbi.nlm.nih.gov/40868276/) (Biomedicines, 2025, PMID:40868276)

[Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders.](https://pubmed.ncbi.nlm.nih.gov/37720552/) (Frontiers in molecular neuroscience, 2023, PMID:37720552)

[RNA-binding protein dysfunction in neurodegeneration.](https://pubmed.ncbi.nlm.nih.gov/34927200/) (Essays in biochemistry, 2021, PMID:34927200)

📖 View canonical wiki page →

Related Entities

mechanisms-stress-granule-disease-comparison

▸Metadataorigin_type: v1_polymorphic_backfill

slug	mechanisms-stress-granule-disease-comparison
kg_node_id	None
entity_type	mechanism
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-9164c4688f71
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'mechanisms-stress-granule-disease-comparison'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

183

Outgoing

270

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

stress-granule-disease-comparison

Stress Granule Dysfunction: Cross-Disease Comparison

Overview

Cross-Disease Comparison Matrix

Stress Granule Dysfunction: Cross-Disease Comparison

Overview

Cross-Disease Comparison Matrix

Disease-Specific Mechanisms

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Frontotemporal Dementia

Huntington's Disease

Liquid-Liquid Phase Separation in Neurodegeneration

LLPS Fundamentals

Cross-Disease LLPS Mechanisms

Shared Molecular Mechanisms

Stress Granule Lifecycle Dysfunction

Therapeutic Targets

RNA Granule Trafficking

Motor Proteins and Transport Machinery

Transport Mechanisms

Disease-Specific Transport Dysfunction

Alzheimer's Disease

Parkinson's Disease

ALS/FTD

Huntington's Disease

Therapeutic Targets for Transport

Transport Assays

Clinical Trials

Biomarkers

Fluid Biomarkers

Imaging Biomarkers

References

💬 Discussion